Literature DB >> 22186318

Preparation and characterization of chloramphenicol niosomes and comparison with chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis in albino rabbits.

Muhammad Naveed Yasin1, Shahzad Hussain, Farnaz Malik, Abdul Hameed, Tipu Sultan, Fahim Qureshi, Humayun Riaz, Ghazala Perveen, Amina Wajid.   

Abstract

Niosomes has gained tremendous popularity as ultimate drug carrier. Lot of research work is being carried out on preparation of niosomes for ophthalmic use having no significant effect on vision and its sustained release pattern. Chloramphenicol niosomes were prepared using two different ratios of cholesterol, drug and surfactant, termed as EIN-1, EIN-2 by ether injection method and their entrapment efficiency, particle size. The in vitro drug release pattern was observed for ten hours. The EIN-2 showed 90% entrapment and released 81% of entrapped drug after 10 hours. Zeta potential & viscosity were determined and in-vivo comparison was made with Chloramphenicol eye drops where it exhibited Cmax of 15 μ g/ml. Stability studies were done to determine shelf life. MIC of selected strain of S. aureus was also determined. EIN 2 niosomal suspension was compared with Chloramphenicol eye drops in experimental conjunctivitis in albino rabbits. In-vitro studies are encouraging as niosomes released about 75% of total entrapped drug by EIN-1 and 81% of total entrapped drug by EIN 2. In vivo study shows that niosomes released the drug in eye in acceptable range and showed a sustained release pattern without affecting the vision. Niosomes were found ultimate ophthalmic drug carriers capable to release drug in sustained and determined pattern.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22186318

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  4 in total

1.  Effects of carvedilol reduce conjunctivitis through changes in inflammation, NGF and VEGF levels in a rat model.

Authors:  Ying Chen; Xianfei Hong
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

2.  Physicochemical and Stability Evaluation of Topical Niosomal Encapsulating Fosinopril/γ-Cyclodextrin Complex for Ocular Delivery.

Authors:  Hay Marn Hnin; Einar Stefánsson; Thorsteinn Loftsson; Rathapon Asasutjarit; Dusadee Charnvanich; Phatsawee Jansook
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

3.  Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency.

Authors:  Meng Zhong; Yue Feng; Hong Liao; Xueyuan Hu; Shengli Wan; Biyue Zhu; Mi Zhang; Huarong Xiong; Yunli Zhou; Jingqing Zhang
Journal:  Pharm Res       Date:  2014-09-11       Impact factor: 4.200

4.  Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes.

Authors:  Leanne De Silva; Ju-Yen Fu; Thet Thet Htar; Saravanan Muniyandy; Azahari Kasbollah; Wan Hamirul Bahrin Wan Kamal; Lay-Hong Chuah
Journal:  Int J Nanomedicine       Date:  2019-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.